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Background: Previous studies revealed that surgical lungbiopsy inusual interstitial pneumonia (UIP)
patients is accompanied with higher morbidity and mortality. The aim of this retrospective analysis
was toassessmorbidity andmortality ofpatientswith suspectedUIPundergoing surgical lungbiopsy.
Methods: Weconducted a retrospective study of 45 patientswith suspected UIP pattern undergoing
surgical biopsy for diffuse pulmonary infiltrates in our department. Data concerningmedical history,
histology, and survival status were extracted from the medical database of the University Medical
Center Freiburg.
Results: UIPwasdiagnosedbyexperiencedpneumo-pathologists according to the criteria ofAmer-
icanThoracic Society/EuropeanRespiratory Society (ATS/ERS) consensus classification. Due to ad-
hesions the surgeon decided in two patients to perform wedge resection via open surgery. In 43
patients lung biopsy was performed via Video-assisted thoracoscopy (VATS). No intraoperative
complications were observed. Postoperative complications consisted of bradyarrhythmia
(nZ 1), gastrointestinal bleeding (nZ 1), bacterial pneumonia (nZ 1), candida pneumonia
(nZ 1) and acute exacerbation (nZ 1). There was no 30-day mortality, but one patient was lost
in follow-up and therefore censored. The intraoperative placed thoracic drainwas removed at the
first postoperative day inmost cases (mean day of removal 1.9,2.6). Themean length of hospital
stay was 8.1 days (6.8).) 761 270 24570; fax: þ49 (0) 761 270 24990.
klinik-freiburg.de, Till_ploenes@gmx.de (T. Plo¨nes).
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Idiopathic pulmonary fibrosis (IPF) is a rare, fatal lung dis-
ease with a median survival of 2.8 years.1,2 It is defined as
a specific form of chronic, progressive fibrosing intestinal
pneumonia of unknown cause, occurring primarily in older
adults, limited to the lungs and associated with the histo-
pathologic and/or radiologic pattern of UIP.2 The diagnosis
of IPF is mainly based on a combination of clinical and
radiographic findings. Histological confirmation via lung
biopsy is not generally recommended. Due to the high
specificity of the UIP pattern on high-resolution computed
tomography (HRCT) histopathological examination of lung
biopsy specimen is only needed in selected cases, although
relative accuracy of HRCT vs. surgical biopsy is very con-
troversial in finding the diagnosis of UIP. However, there are
only very few studies reporting the surgical outcome of
patients affected by UIP undergoing lung biopsy.3,4 Utz J.P.
et al. published a case series with sixteen patients under-
going VATS and fourty-four undergoing thoracoctomy.4 The
author reported a high 30-day mortality rate of 14%, which
is unusually high compared to patients undergoing VATS for
other reasons. Titto L. et al. demonstrated that VATS is
a safe procedure in seventy-six UIP-patients. Fourty-two
patients diagnosed via open lung biopsy showed in this
study a 30-day mortality of 5.3%. Postoperative respiratory
complications are the most important, life threatening
events in patients undergoing lung surgery.5 Patients suf-
fering from lung fibrosis are compromised respiratorily and
acute exacerbation (AE) is an additional important com-
plication which can occur in the early postoperative phase
of these patients.5 AE is defined as an acute, clinically
significant deterioration of unidentifiable cause.6 It may
overlap with acute respiratory distress syndrome (ARDS) or
other acute postoperative failures like postoperative
pneumonia.7,8
The aim of this study was to investigate the morbidity
and mortality in patients with suspected UIP undergoing
surgical lung biopsy in our department.Material and methods
Patients and surgical techniques
We conducted a retrospective review of 45 patients in
which a UIP was diagnosed after surgical lung biopsy for
diffuse pulmonary infiltrates between November 2000 and
August 2011 in our department. UIP pattern was diagnosed
by experienced pneumo-pathologists according to the cri-
teria of American Thoracic Society/European Respiratory
Society (ATS/ERS) consensus classification.2 In all cases
histological pattern, clinical findings and HRCT were dis-
cussed interdisciplinary. Data concerning medical history,
histology, clinical parameters and survival status wereextracted from the medical database of the University
Medical Center Freiburg. All patients underwent a com-
plete preoperative workup including spirometry and blood
gas analysis. VATS and mini-thoracotomy were performed
as a standard procedure. The evaluation of lung function
was assessed according to the guidelines of ERS/ATS.9e12
Each parameter was specified in percentage predicted of
normal (%). Respiratory complications were classified with
the criteria of Collard H.R. et al.6 The American Society of
Anesthesiology (ASA) score was assessed according to the
guidelines of ASA.13
30-day mortality
30-day mortality was calculated from the date of surgical
procedure. If possible basic information was retrieved by
medical records of the Medical Department of University
Center Freiburg, from the general practitioner or by
structured interviews by telephone (performed by T.P.).
A minimum follow-up of 30 days is available for each pa-
tient except for one patient, who was therefore censored
from further analysis.
Statistical analysis
Values are given as mean with SD in parentheses. We used
no statistical test, because of the descriptive character of
this paper.
Ethics statement
All patients, who were treated in our department provided
a written informed consent that medical datas can be used
for scientific reasons in an anonymous way. This was
approved by the Ethics Committee of the University Medical
Center Freiburg.
Results
Patients characteristics
The study population consists in 45 patients in which a UIP
was diagnosed after surgical biopsy. There were 36 male
(80%) and 9 (20%) women with a median age of 61.4 years
(range 25.2e79.1 years). ASA physical status revealed
18 patients as ASA II, 22 patients classified as ASA III and one
patient as ASA IV. In 4 cases patients were not classified ac-
cording to the ASA criteria or ASA classification was not
documented. Mean body mass index (BMI) was 27.2 (4.9)
(Table 1). Due to pleural adhesions of the lung the surgeon
decided to perform wedge resection via open surgery in two
patients. VATS was performed in 43 patients. The mean
number lung biopsies was 1.7 biopsies per patient (0.4) and
most biopsies were taken from middle lobe plus lower lobe
Table 3 Performed surgical procedures.
Characteristics Value
Total N Z 45
Lung biopsies Mean count 1.7 (0.4)
Localization of
taken biopsiesa
ML þ LL 15
LL þ UL 11
LL 7
UL 6
ML þ UL 4
ML 2
Performed surgical
procedure
VATSb 43
Open surgery 2
Side of intervention Left 12
Right 33
a ML: middle lobe, UL: upper lobe, LL: lower lobe.
b VATS: Video-assisted thoracoscopic surgery.
Table 1 Patients characteristics.
Characteristics Value
Total N Z 45
Gender Female 9
Male 36
Median age 61 years (range
25e79 years)
ASA classificationa ASA I 0
ASA II 18
ASA III 22
ASA IV 4
ASA not documented 1
BMIb 27.2 (4.9)
a ASA physical status according to the American Society of
Anesthesiology.
b Body mass index.
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lobe (nZ 11), lower lobe (nZ 7), upper lobe (nZ 6), middle
lobe plus upper lobe (nZ 4) and middle lobe alone (nZ 2)
(Table 2). The majority of patients was biopsied on the right
side (nZ 33) and only in a few patients the biopsy was taken
from the left side (n Z 12) (Table 3). None of the patients
developed intraoperative complications. Postoperative
complications consisted of bradyarrhythmia (n Z 1), gas-
trointestinal bleeding (nZ 1), bacterial pneumonia (nZ 1),
candida pneumonia (n Z 1) and AE (n Z 1). The 30-day
mortality was 0%, but one patient was lost in follow-up and
therefore censored. (Table 4). The intraoperative placed
thoracic drain was removed at the first postoperative day
(meandayof removal 1.9,2.6). Themean lengthof hospital
stay was 8.1 days (6.8).Lung function test prior surgical procedure and
smoking status
Most patients (86%) were non-smokers (n Z 39), 14% were
smokers (n Z 6), mostly with a heavy abuse of nicotine
(range 8e40 Py). Mean forced expiratory volumen in 1 s
(FEV1) was 71% (range from 22% to 112%). Median forced
vital capacity (FVC) was 66% (range from 13% to 110%).Table 2 Smoking status and lung function prior surgical
procedure.
Characteristics Value
Total N Z 45
Smoker Yes 6
No 39
FEV1
a 71% (range 22e112%)
FVCb 66% (range 13e110%)
DLCOc 45% (range 23e66%)
a Forced expiratory volumen in 1 s specified in percentage
predicted to normal.
b Forced vital capacity specified in percentage predicted to
normal.
c Diffusing capacity for carbon monoxide.Median diffusion capacity for carbon monoxide (DLCO) was
45% (range 23e66%).
Discussion
After the introduction of the video-assisted approach in
modern thoracic surgery the morbidity and mortality has
decreased, even if extended resections are performed.14
The largest studies of VATS lobectomies reported morbidity
and mortality rates comparable to the thoracotomy
approach. Morbidity ranges between 3% and 13%, whereas
mortality is between 0% and 2%. Even investigating high-risk
subgroups, mortality is in most studies not much higher than
10%.14 Therefore it was notable that Utz J.P. et al. reported
a surprisingly high 30-day mortality of 21.7% in a cohort of
patients with diagnosed UIP pattern undergoing surgical bi-
opsy.4 A few years later Titto L. et al., reported amortality of
5.3% and identified the age of the patients at the time of
biopsy as a risk factor.3 However, verified histopathological
diagnosis is often necessary to make therapeutic decisions
and helps treatment planning in patients with unclear in-
filtrates of the lung. Therefore, we reviewed our own expe-
riencewith lung biopsies in the selected subgroup of patientsTable 4 Morbidity and mortality of patients with histo-
logically proofen UIP.
Characteristics Value
Intraoperative
complications
0%
Postoperative
complications
11% (n Z 5/45)
Type of
postoperative
complications
Bradyarrhythmia 2% (n Z 1/45)
Bacterial Pneumonia 2% (n Z 1/45)
Candida Pneumonia 2% (n Z 1/45)
Acute exacerbation 2%(n Z 1/45)
Gastrointestinal
bleeding
2% (n Z 1/45)
30 days mortalitya 0% (n Z 0/44)
a One patient was lost in follow-up and therefore censored.
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group of the remaining 44 patients 30-day mortality was 0%.
Themorbidity rate was low and postoperative complications
contained pneumonia and arrhythmia, which is not unusual
after a thoracic surgical procedure. Only one patient suf-
fered from AE, but all patient survived and in no case rein-
tubation and invasive ventilation was necessary. The early
removement of the intraoperative placed thoracic drainage
and the early discharge of patients are clear indicators for
early convalescence, although patients were mostly critical
ill related to the ASA score. The patients in this study, as well
as in the studies of Utz J.P. et al. and Titto L. et al., are highly
selected pulmonary risk patients, not presenting the typical
UIP patient. Most of them underwent surgical lung biopsy to
clarify the diagnosis, because of atypical findings in clinical
history, in physical examination or in HRCT. Lacking of large
prospective studies makes it difficult to asses the risk of lung
biopsy in patients affected by UIP.
Regardless, we conclude from our data that performing
surgical biopsy via VATS is possible with a low morbidity and
no mortality in these patients.
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